FAPI-PET Scan for Esophageal Cancer Surgery Planning
Part of Cancer, Digestive system clinical trials.
This trial tests whether a special PET scan called FAPI-PET can better show the edges of esophageal tumors before surgery. It may help doctors plan more precise surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of adenocarcinoma or squamous cell carcinoma of the esophagus (including AEG I or II).
- Your treatment plan must include surgery to remove the tumor.
- You need to be generally well enough to care for yourself (ECOG 0/1 or Karnofsky index of 60% or more).
- You must be at least 18 years old.
- You cannot have had radiation to the tumor area before, nor have cancer that has spread to distant organs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan to look at diseases like cancer. It aims to see if this new imaging method can help doctors find or monitor disease better. This could be helpful for people with confirmed or suspected cancer or other conditions.
This trial tests a new PET scan drug (18F-FAPI) to see if it can better detect where stomach or esophageal cancer has spread. It may help doctors plan the right treatment for you.
This trial tests whether a special PET/CT scan (using a drug called [18F]F-FAPI) and a laparoscopy (a small camera through the belly) can better show the spread of advanced stomach or esophagus cancer before surgery. The goal is to help doctors decide the best treatment plan.
This trial uses a special PET/CT scan to see how well your esophageal cancer responds to chemotherapy and radiation. It helps doctors find out if the treatment is working early on.
This trial is testing a new imaging method called FAPI-PET to see if it can help find and understand tumors better than standard scans. It is for people with newly diagnosed stomach/esophageal cancer, pancreatic cancer, or those with unclear symptoms or scan results.
This study tests whether a special imaging scan (functional imaging) can identify which esophageal cancers respond best to radiation. If you have stage II–IVA esophageal cancer and meet the health criteria, joining may help personalize your treatment.
Hear when a new Esophagus Cancer, Stage I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.